Your browser doesn't support javascript.
loading
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.
Cazaubiel, Titouan; Leleu, Xavier; Perrot, Aurore; Manier, Salomon; Buisson, Laure; Maheo, Sabrina; Do Souto Ferreira, Laura; Lannes, Romain; Pavageau, Luka; Hulin, Cyrille; Marolleau, Jean-Pierre; Voillat, Laurent; Belhadj, Karim; Divoux, Marion; Slama, Borhane; Brechignac, Sabine; Macro, Margaret; Stoppa, Anne-Marie; Sanhes, Laurence; Orsini-Piocelle, Frédérique; Fontan, Jean; Chretien, Marie-Lorraine; Demarquette, Hélène; Mohty, Mohamad; Schavgoulidze, Anais; Avet-Loiseau, Herve; Corre, Jill.
Afiliação
  • Cazaubiel T; Department of Hematology, University Hospital, Bordeaux, France.
  • Leleu X; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.
  • Perrot A; Department of Hematology, University Hospital, Poitiers, France.
  • Manier S; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.
  • Buisson L; Department of Hematology, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
  • Maheo S; Department of Hematology, University Hospital, Lille, France.
  • Do Souto Ferreira L; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.
  • Lannes R; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
  • Pavageau L; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.
  • Hulin C; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
  • Marolleau JP; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.
  • Voillat L; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
  • Belhadj K; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.
  • Divoux M; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
  • Slama B; Bioinformatics Department, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Brechignac S; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.
  • Macro M; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
  • Stoppa AM; Department of Hematology, University Hospital, Bordeaux, France.
  • Sanhes L; Department of Hematology, University Hospital, Amiens, France.
  • Orsini-Piocelle F; Department of Hematology, Hospital, Chalon-sur-Saône, France.
  • Fontan J; Department of Hematology, University Hospital, Créteil, France.
  • Chretien ML; Department of Hematology, University Hospital, Nancy, France.
  • Demarquette H; Department of Hematology, Hospital, Avignon, France.
  • Mohty M; Department of Hematology, University Hospital, Bobigny, France.
  • Schavgoulidze A; Department of Hematology, University Hospital, Caen, France.
  • Avet-Loiseau H; Department of Hematology, Institut Paoli Calmettes, Marseille, France.
  • Corre J; Department of Hematology, Hospital, Perpignan, France.
Blood ; 139(17): 2666-2672, 2022 04 28.
Article em En | MEDLINE | ID: mdl-35171994

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Plasmocitária / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Plasmocitária / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França